WE COMMERCIALIZE INNOVATIVE PRODUCTS

 

We offer highly flexible, tailored partnership models for the direct European commercialization of specialty, rare/orphan and hospital products, and we build and manage rightsized go-to-market organizations on our partners’ behalf.

Our value proposition bridges the gap between traditional go-it-alone and out-licensing strategies by providing a low risk shared-value approach.

 

FLEXIBLE COMMERCIALIZATION MODELS

For partners aiming to achieve an European footprint, we build and manage a dedicated go-to-market organization in the major European markets.

 

For smaller assets that do not justify building a dedicated organization, Vicarius Pharma manages multiple, non-competing assets in aligned therapeutic areas, passing the synergies on to our partners in the form of improved economic terms.

 

Whatever European market entry solution best fits their strategy, our partners work closely with a highly experienced and well connected European Executive Team – from day one of the partnership.

 

BUILDING AND MANAGING RIGHT-SIZED GO-TO-MARKET ORGANIZATIONs

We commercialize our partners products on their behalf and in their name. Our partnering models are tailored to fit our partners’ strategic goals and allow them the option to recapture the asset and, if desired, the commercial organization we have built at any time of the partnership.

 

Our executive team provides excellence over the whole spectrum of direct European commercialization, including:  sales & marketing, regulatory filing, IP protection, market access, P&R negotiations, product launch, stakeholder management and maintenance of long-term value.

 

WE OFFER SHARED VALUE

 

Our partnering models are based on a value-sharing principle and are shaped to fit our partners’ strategy.

 

STRATEGIC FIT WITH LONG-TERM GOALS

Our deal structures are fully aligned with our partners’ strategic priorities, giving them the option to assume direct commercialization of the asset as their strategy and geographic reach evolve.

 

WE ABSORB LAUNCH COSTS

Vicarius Pharma absorbs launch costs, thereby protecting our partners’ P&L. Our partnership terms are based on a shared-value approach and more attractive than typical out-licensing terms.

 

WE ACT ON OUR PARTNERS’ BEHALF

 

We own our partners success, and invest and execute at risk. With Vicarius Pharma, our partners access the European market with a nimble and trusted expert.

 

A PROVEN, READY-NOW, EXECUTIVE TEAM

We know the European pharmaceutical market inside out and leverage our unmatched expertise and unparalleled access to KOLs and other key stakeholders for the success of our partners’ products.

 

CROSS-FUNCTIONAL EXPERTISE

We have excellent cross-functional expertise to lead the assets through all the post-R&D functions: regulatory filing, IP protection, market access, P&R negotiations, product launch, stakeholder management and maintenance of long-term value.

 

Pre-launch activities

Post-launch activities

  • Country prioritization

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Regulatory fillings

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Organizational development/staffing

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Supply chain coordination

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Market access preparation

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • P&R negotiations

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Commercial planning

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Legal contracting

 

  • Dedicated Key Account Managers

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Dedicated Market Access Managers

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Dedicated Medical Scientific Liaisons

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Medical writing / communications

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Ongoing regulatory / market access requirements

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Ongoing supply chain coordination

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Back office support

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Geographical opportunity screening

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

  • Third-party coordination for
    geographical expansion

Highest ethical standards

We are experts in implementing programs that comply with EU and US legal requirements and execute them in accordance with the highest ethical standards.